OTC Markets OTCPK - Delayed Quote USD

OpGen, Inc. (OPGN)

4.9100
+0.3000
+(6.51%)
At close: May 9 at 3:15:32 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,265.8680
3,418.3200
2,607.2930
4,306.0310
4,214.4410
Cost of Revenue
1,211.0770
3,509.0140
3,423.9910
2,848.4480
3,848.4910
Gross Profit
54.7910
-90.6940
-816.6980
1,457.5830
365.9500
Operating Expense
6,027.6840
15,597.7830
21,402.1750
24,559.9050
21,860.4730
Operating Income
-5,972.8930
-15,688.4770
-22,218.8730
-23,102.3220
-21,494.5230
Net Non Operating Interest Income Expense
154.3000
-1,696.4450
-3,209.4750
-4,754.1520
-3,293.7570
Other Income Expense
-3,580.3580
-15,283.6080
-11,854.8850
-6,905.4100
-1,290.1610
Pretax Income
-9,398.9510
-32,668.5300
-37,283.2330
-34,761.8840
-26,078.4410
Tax Provision
0
0
0
43.8280
132.4030
Net Income Common Stockholders
-9,918.1120
-32,668.5300
-37,283.2330
-41,972.4640
-26,210.8440
Diluted NI Available to Com Stockholders
-9,918.1120
-32,668.5300
-37,283.2330
-41,972.4640
-26,210.8440
Basic EPS
-36.58
-41.47
-152.70
-228.00
-332.00
Diluted EPS
-36.95
-41.47
-152.70
-228.00
-332.00
Basic Average Shares
8,355.4960
787.8320
244.1580
183.3700
79.0030
Diluted Average Shares
8,355.4960
787.8320
244.1580
183.3700
79.0030
Total Operating Income as Reported
-21,033.0710
-30,748.6550
-34,567.1210
-23,273.0360
-22,718.4790
Total Expenses
7,238.7610
19,106.7970
24,826.1660
27,408.3530
25,708.9640
Net Income from Continuing & Discontinued Operation
-9,398.9510
-32,668.5300
-37,283.2330
-34,805.7120
-26,210.8440
Normalized Income
-6,727.1790
-17,384.9220
-25,428.3480
-29,764.7627
-24,927.1338
Interest Income
298.9860
142.4880
46.9350
45.1790
105.6270
Interest Expense
144.6860
1,838.9330
3,256.4100
4,799.3310
3,399.3840
Net Interest Income
154.3000
-1,696.4450
-3,209.4750
-4,754.1520
-3,293.7570
EBIT
-9,254.2650
-30,829.5970
-34,026.8230
-29,962.5530
-22,679.0570
EBITDA
-8,876.7470
-29,511
-32,384.0420
-27,248.6460
-20,344.3180
Reconciled Cost of Revenue
1,211.0770
3,509.0140
3,423.9910
2,848.4480
3,848.4910
Reconciled Depreciation
377.5180
1,318.5970
1,642.7810
2,713.9070
2,334.7390
Net Income from Continuing Operation Net Minority Interest
-9,398.9510
-32,668.5300
-37,283.2330
-34,805.7120
-26,210.8440
Total Unusual Items Excluding Goodwill
-2,671.7720
-15,283.6080
-11,854.8850
-6,905.4100
-1,290.1610
Total Unusual Items
-2,671.7720
-15,283.6080
-11,854.8850
-6,905.4100
-1,290.1610
Normalized EBITDA
-6,204.9750
-14,227.3920
-20,529.1570
-20,343.2360
-19,054.1570
Tax Rate for Calcs
0
0
0
0.0003
0
Tax Effect of Unusual Items
0
0
0
-1,864.4607
-6.4508
12/31/2020 - 5/5/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

INBS Intelligent Bio Solutions Inc.
1.2100
+0.83%
 
AIMD Ainos, Inc.
0.5396
-1.89%
 
ALNOV.PA Novacyt S.A.
0.4575
-0.11%
 
BBLG Bone Biologics Corporation
0.7497
+8.65%
 
AEMD Aethlon Medical, Inc.
0.3660
-0.79%
 
TIVC Tivic Health Systems, Inc.
3.9400
-5.06%
 
CODX Co-Diagnostics, Inc.
0.3399
-4.31%
 
SGHT Sight Sciences, Inc.
3.0800
+1.65%
 
HSCS HeartSciences Inc.
3.4286
-1.76%
 
BJDX Bluejay Diagnostics, Inc.
1.7500
-0.57%